Jane Street
AXSM icon

Jane Street’s Axsome Therapeutics AXSM Stock Holding History

Jane Street’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9M Buy
82,500
+27,700
+51% +$4.78M ﹤0.01% 2140
2025
Q4 		$10M Buy
54,800
+1,500
+3% +$209K ﹤0.01% 2314
2025
Q3 		$6.47M Buy
53,300
+32,500
+156% +$3.66M ﹤0.01% 3031
2025
Q2 		$2.17M Sell
20,800
-63,100
-75% -$6.68M ﹤0.01% 4289
2025
Q1 		$9.79M Sell
83,900
-76,500
-48% -$8.72M ﹤0.01% 2012
2024
Q4 		$13.6M Buy
160,400
+52,100
+48% +$4.79M ﹤0.01% 1614
2024
Q3 		$9.73M Buy
108,300
+77,000
+246% +$6.72M ﹤0.01% 1936
2024
Q2 		$2.52M Sell
31,300
-225,900
-88% -$16.7M ﹤0.01% 4106
2024
Q1 		$20.5M Buy
257,200
+198,100
+335% +$16.6M ﹤0.01% 1165
2023
Q4 		$4.7M Sell
59,100
-10,400
-15% -$695K ﹤0.01% 2943
2023
Q3 		$4.86M Sell
69,500
-21,000
-23% -$1.57M ﹤0.01% 2652
2023
Q2 		$6.5M Sell
90,500
-13,000
-13% -$959K ﹤0.01% 2396
2023
Q1 		$6.38M Sell
103,500
-56,400
-35% -$3.71M ﹤0.01% 2120
2022
Q4 		$12.3M Buy
159,900
+1,300
+0.8% +$77.7K 0.01% 1416
2022
Q3 		$7.08M Sell
158,600
-98,400
-38% -$4.92M ﹤0.01% 2112
2022
Q2 		$9.84M Buy
257,000
+226,800
+751% +$7.17M ﹤0.01% 1760
2022
Q1 		$1.25M Sell
30,200
-20,900
-41% -$648K ﹤0.01% 5661
2021
Q4 		$1.93M Sell
51,100
-73,800
-59% -$2.72M ﹤0.01% 4569
2021
Q3 		$4.12M Sell
124,900
-153,600
-55% -$5.99M ﹤0.01% 3061
2021
Q2 		$18.8M Sell
278,500
-85,000
-23% -$5.1M 0.01% 1120
2021
Q1 		$20.6M Buy
363,500
+170,800
+89% +$12M 0.01% 945
2020
Q4 		$15.7M Sell
192,700
-153,300
-44% -$11.5M 0.01% 1049
2020
Q3 		$24.7M Buy
346,000
+3,000
+0.9% +$234K 0.01% 662
2020
Q2 		$28.2M Buy
343,000
+303,100
+760% +$23.3M 0.02% 578
2020
Q1 		$2.35M Buy
39,900
+18,600
+87% +$1.52M ﹤0.01% 1864
2019
Q4 		$2.2M Buy
+21,300
New +$860K ﹤0.01% 1837

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's AXSM Position: Q1 2026 in Review

Jane Street reduced its Axsome Therapeutics (AXSM) stake by 97% in Q1 2026, selling an estimated $23M and leaving 4,078 shares worth $689K. The position accounts for ﹤0.01% of the portfolio, ranked #7302.

Jane Street first reported a position in AXSM in Q1 2019 and has held it in 28 quarters since. The position peaked at $25.1M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Jane Street held 4,078 shares of Axsome Therapeutics worth $689K as of Q1 2026.
  • Jane Street sold 133,205 Axsome Therapeutics shares in Q1 2026, an estimated $23M.
  • Axsome Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #7302 holding.
  • Jane Street first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 28 quarters since.
  • Jane Street's Axsome Therapeutics position peaked at $25.1M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.